<DOC>
	<DOCNO>NCT02084576</DOCNO>
	<brief_summary>To compare anti-inflammatory efficacy ketorolac tromethamine 0.4 % nepafenac 0.1 % eye drop prophylaxis cystoid macular edema ( CME ) small-incision cataract extraction .</brief_summary>
	<brief_title>Anti-inflammatory Efficacy Prophylaxis Cystoid Macular Edema ( CME ) After Phacoemulsification</brief_title>
	<detailed_description>This prospective randomized clinical trial study include patient old 40 year age-related cataract , normal ophthalmologic examination besides senile cataract . Exclusion criterion previous ocular surgery , central endothelial cell count less 2000 cells/mm2 , glaucoma intraocular pressure great 21 mmHg , amblyopia , retinal abnormality , steroid immunosuppressive treatment , connective tissue disease , allergy hypersensitivity NSAIDs . Enrolled patient complicate cataract surgery ( eg , posterior capsule rupture , vitreous loss , intraocular lens place capsular bag ) subsequently exclude . Study Protocol Preoperatively , patient extensive ophthalmologic examination , include measurement correct distance visual acuity ( CDVA ) , refraction , slitlamp examination , intraocular pressure ( IOP ) , fundoscopy , corneal endothelial cell count noncontact specular microscopy ( Noncon Robo , Konan ) , central corneal thickness ( CCT ) measurement ( Pentacam , Oculus , Inc. ) , biometry IOLMaster partial coherence interferometry device ( Carl Zeiss Meditec AG ) . The targeted postoperative refractive error 0.0 D. The visual acuity measurement record logMAR UDVA CDVA . In addition , baseline spectral-domain OCT ( SD-OCT ) scan perform surgery postoperatively 1 , 4 12 week . All SD-OCT imaging perform spectral-domain Heidelberg Spectralis OCT devise ( Heidelberg Engineering , Inc. , Heidelberg , Germany ) . Patients assign 1:1 ration 1 2 treatment group use computer-generated randomization list . The study medication ketorolac tromethamine 0.4 % ( Acular LS , Allergan ) group 1 , nepafenac 0.1 % ( Nevanac , Alcon ) group 2 . Patients instruct instill ketorolac tromethamine 0.4 % 1 drop operative eye 4 time day ( breakfast , lunch , dinner , bedtime ) , nepafenac 0.1 % 1 drop 3 time day .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Patients older 40 year agerelated cataract , normal ophthalmologic examination besides senile cataract . Previous ocular surgery , central endothelial cell count less 2000 cells/mm2 , glaucoma intraocular pressure great 21 mmHg , amblyopia , retinal abnormality , steroid immunosuppressive treatment , connective tissue disease , allergy hypersensitivity NSAIDs . Enrolled patient complicate cataract surgery ( eg , posterior capsule rupture , vitreous loss , intraocular lens place capsular bag ) subsequently exclude</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Cystoid macular edema</keyword>
	<keyword>nonsteroidal anti-inflammatory drug</keyword>
	<keyword>OCT</keyword>
	<keyword>phacoemulsification .</keyword>
</DOC>